Working… Menu

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo (EBOVAC-Salone)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02509494
Recruitment Status : Completed
First Posted : July 28, 2015
Last Update Posted : November 4, 2019
London School of Hygiene and Tropical Medicine (LSHTM)
Ministry of Health and Sanitation of Sierra Leone
College of Medicine and Allied Health Sciences (COMAHS)
University of Oxford
Institut National de la Santé Et de la Recherche Médicale, France
Grameen Foundation
World Vision of Ireland
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 28, 2019
Actual Study Completion Date : July 3, 2019